Literature DB >> 8617342

Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.

N Ahlborg1, J Iqbal, L Björk, S Ståhl, P Perlmann, K Berzins.   

Abstract

Plasmodium falciparum-reactive antibodies can inhibit growth of parasite blood stages in vitro by interfering at different stages of parasite development. Antibodies reactive with repeat sequences in Pf155/ring-infected surface antigen (Pf155/RESA) or in antigen Pf332 inhibit parasite growth as determined by a reduction of newly infected erythrocytes. Antibodies to Pf155/RESA have been implicated in merozoite invasion inhibition. Since it was considered unlikely that antibodies to the late stage antigen Pf332 act on merozoite invasion, we investigated at what developmental stage this growth inhibition takes place. Parasites were cultured in the presence of antibodies to repeat sequences of either Pf332 or Pf155/RESA and were examined with regard to the distribution of different stages and their morphology. As expected, antibodies to both antigens decreased the number of ring stages after reinfection. They did not affect the intraerythrocytic development of ring stages or trophozoites. However, antibodies to Pf332 induced high levels of schizonts displaying an abnormal morphology while antibodies to Pf155/RESA induced considerably lower levels of degenerated schizonts. Thus, Pf332-reactive antibodies seem to interfere with the schizont development by blocking the rupture of mature schizonts or, alternatively, by interfering intraerythrocytically with late stage parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617342     DOI: 10.1006/expr.1996.0020

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  13 in total

1.  Isolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage.

Authors:  C G Adda; L Tilley; R F Anders; M Foley
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.

Authors:  Dipak K Raj; Christian P Nixon; Christina E Nixon; Jeffrey D Dvorin; Christen G DiPetrillo; Sunthorn Pond-Tor; Hai-Wei Wu; Grant Jolly; Lauren Pischel; Ailin Lu; Ian C Michelow; Ling Cheng; Solomon Conteh; Emily A McDonald; Sabrina Absalon; Sarah E Holte; Jennifer F Friedman; Michal Fried; Patrick E Duffy; Jonathan D Kurtis
Journal:  Science       Date:  2014-05-23       Impact factor: 47.728

3.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.

Authors:  Peter D Crompton; Matthew A Kayala; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Greta E Weiss; Douglas M Molina; Chad R Burk; Michael Waisberg; Algis Jasinskas; Xiaolin Tan; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; David L Narum; Xiaowu Liang; Ogobara K Doumbo; Louis H Miller; Denise L Doolan; Pierre Baldi; Philip L Felgner; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 4.  Methodology and application of flow cytometry for investigation of human malaria parasites.

Authors:  Brian T Grimberg
Journal:  J Immunol Methods       Date:  2011-02-04       Impact factor: 2.303

5.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.

Authors:  E Israelsson; H Balogun; N-M Vasconcelos; J Beser; C Roussilhon; C Rogier; J F Trape; K Berzins
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

7.  Functional alteration of red blood cells by a megadalton protein of Plasmodium falciparum.

Authors:  Fiona K Glenister; Kate M Fernandez; Lev M Kats; Eric Hanssen; Narla Mohandas; Ross L Coppel; Brian M Cooke
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

8.  Characterization of the Duffy-Binding-Like Domain of Plasmodium falciparum Blood-Stage Antigen 332.

Authors:  Sandra Nilsson; Kirsten Moll; Davide Angeletti; Letusa Albrecht; Inari Kursula; Ning Jiang; Xiaodong Sun; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  Malar Res Treat       Date:  2011-09-19

9.  Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum.

Authors:  Anthony N Hodder; Alexander G Maier; Melanie Rug; Monica Brown; Mirja Hommel; Ivan Pantic; Marina Puig-de-Morales-Marinkovic; Brian Smith; Tony Triglia; James Beeson; Alan F Cowman
Journal:  Mol Microbiol       Date:  2008-11-05       Impact factor: 3.501

10.  MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum.

Authors:  Elke S Bergmann-Leitner; Elizabeth H Duncan; Evelina Angov
Journal:  Malar J       Date:  2009-08-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.